Radiolabelled white blood cell scintigraphy in the work-up of dermal filler complications

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 3, 2013, Pages 418-425

  Grippaudo, F R ^a   Pacilio, M ^a   Di Girolamo, M ^a   Dierckx, R A ^b   Signore, A ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Dermal filler; Infection; Scintigraphy; WBC

Indexed keywords

DERMAL FILLER; FILLER; GADOLINIUM PENTETATE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOFT TISSUE INFECTION; WHITE BLOOD CELL SCINTIGRAPHY;

ADULT; AGED; FEMALE; HUMANS; ISOTOPE LABELING; LEUKOCYTES; MIDDLE AGED; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; TECHNETIUM;

EID: 84874000330     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2305-7     Document Type: Article

References (25)

1. Eppley BL, Dadvand B. Injectable soft tissue fillers: clinical overview. Plast Reconstr Surg. 2006;118:98-106.
2. Broder KW, Cohen SR. An overview of permanent and semipermanent fillers. Plast Reconstr Surg. 2006;118 Suppl:7-14.
3. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal filler: review. Dermatol Surg. 2005;31:1616-25.
4. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg. 2006;118 Suppl:92S-107.
5. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg. 2005;29:34-48.
6. Poveda R, Bagàn JV, Murillo J, Jimnez Y. Granulomatous facial reaction to injected cosmetic fillers. A presentation of five cases. Med Oral Patol Oral Cir Bucal. 2006;11:E1-5.
7. Christensen L. Normal and pathologic tissue reactions to soft tissues gel fillers. Dermatol Surg. 2007;33 Suppl 2:S168-75.
8. Vorne M, Soini I, Lantto T, Paakkinen S. Technetium-99m HMPAO-labeled leucocytes in detection of inflammatory lesions: comparison with gallium-67 citrate. J Nucl Med. 1989;30:1332-6.
9. Hovi I. Complicated bone and soft-tissue infections. Imaging with 0.1 T MR and 99mTc-HMPAO-labeled leukocytes. Act Radiol. 1996;37:870-6.
10. Sayit E, Soylev M, Capa G, Durak I, Ada E, Yilmaz M, Durak H. The role of technetium-99m-HMPAO-labeled WBC scintigraphy in the diagnosis of orbital cellulitis. Ann Nucl Med. 2001;15(1):41-4.
11. Cascini GL, De Palma D, Matteucci F, Biggi A, Rambaldi PF, Signore A, Mansi L. Fever of unknown origin, infection of subcutaneous devices, brain abscesses and endocarditis. Nucl Med Commun. 2006;27(3):213-22.
12. Schütz P, Ibrahim HH, Hussain SS, Ali TS, El-Bassuoni K, Thomas J. Infected facial tissue fillers: case series and review of the literature. J Oral Maxillofac Surg. 2012;70:2403-12.
13. Grippaudo FR, Mattei M. High-frequency sonography of temporary and permanent dermal fillers. Skin Res Technol. 2010;16(3):265-9.
14. Grippaudo FR, Mattei M. The utility of high-frequency ultrasound in dermal filler evaluation. Ann Plast Surg. 2011;67:469-73.
15. de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37(4):842-8.
16. American Society of Plastic Surgeons. 2010 Report of the 2009 Statistics. National Clearinghouse of Plastic Surgery Statistics. Arlington Heights, IL: American Society of Plastic Surgeons; 2010.
17. Zielke H, Wölber L, Wiest L, Rzany B. Risk profiles of different injectable fillers: results from the injectable filler. Safety study (IFS Study). Dermatol Surg. 2008;34(3):326-35.
18. Christensen LH. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg. 2009;35:1612-9.
19. Schelke LW, van der Helzen HJ, Canninga M, Neumann MH. Complications after treatment with polyalkylimide. Dermatol Surg. 2009;35 Suppl:1625-8.
20. Nadarajah JT, Collins M, Raboud J, Su D, Rao K, Loutfy MR, Walmsley S. Infectious complications of bio-alcamid filler used for HIV-related facial lipoatrophy. Clin Infect Dis. 2012;55:1568-74.
21. Rohrich RJ, Monheit G, Nguyen AT, Brown SA, Fagien S. Soft-tissue filler complications: the important role of biofilms. Plast Reconstr Surg. 2010;125(4):1250-6.
22. Park TH, Seo SW, Kim JK, Chang CH. Clinical experience with polymethylmethacrylate microsphere filler complications. Aesthetic Plast Surg. 2012;36(2):421-6.
23. Sanchis-Bielsa JM, Bagàn JV, Poveda R, Salvador I. Foreign body granulomatous reactions to cosmetic fillers: a clinical study of 15 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:237-41.
24. Bjarnsholt T, Tolker-Nielsen T, Givskov M, Jannsen M, Christensen LH. Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg. 2009;35 Suppl 2:1620-4.
25. Vorne M, Laitinen R, Lantto T, Järvi K, Toivio I, Mokka R. Chronic prosthetic vascular graft infection visualized with technetium-99m- hexamethylpropyleneamine oxime-labeled leukocytes. J Nucl Med. 1991;32(7):1425-7.